PANTAGES CAPITAL ACQUISITION Corp

Our units, Class A ordinary shares, Rights were each traded on the Nasdaq Stock Market LLC under the symbols “SPHAU,” “SPHA,” and “SPHAR,” respectively. Our units commenced public trading on December 5, 2024, and our Class A ordinary shares and Rights commenced separate public trading on January 27, 2025. On March 12, 2025, the symbols for our units, ordinary shares and Rights changed from “SPHAU”, “SPHA”, “SPHAR”, in each case to “AIFEU”, “AIFE”, and “AIFER,” which in turn changed in each case to “PGACU”, “PGAC”, and “PGACR”, on August 8, 2025, all of which continue to be traded on the Nasdaq Stock Market LLC

Holders

On December 31, 2025, there were 2 holders of record of our units, 1 holder of record of our Class A ordinary shares, 1 holder of record of our Rights, and 6 holders of record of our Class B ordinary shares.

Securities Authorized for Issuance Under Equity Compensation Plans

None.

Recent Sales of Unregistered Securities

Unregistered Sales of Equity Securities

Founder Shares Sales and Transfer

On June 14, 2024, our CEO, Mr. William W. Snyder, our CFO, Ms. Jia Peng, and Aitefund Sponsor LLC (the “Sponsor”) of our IPO (as defined below), Aitefund Sponsor LLC, acquired an aggregate of 1,725,000 Class B ordinary shares, par value of $0.0001 each (the “founder shares”), for an aggregate purchase price of $25,000. On July 9, 2024, an additional 431,250 founder shares were issued, at par value, to the Sponsor, for the purchase price of $43, resulting that the Sponsor to hold 1,996,250 founder shares.

On December 4, 2024, the effective date of the registration statement of the IPO (as defined below), the Sponsor transferred an aggregate of 60,000 of its founder shares, or 20,000 each to its three independent directors for their board service, for nominal cash consideration, of $696.

Private Placement

On December 6, 2024, simultaneously with the closing of the IPO, the Company completed a private placement (the “Private Placement”) of 244,250 private placement units to the Company’s Sponsor, at a purchase price of $10.00 per private placement units, generating gross proceeds to the Company of $2,442,500.

The above sales were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No commissions were paid in connection with such sales.

Use of Proceeds

On December 6, 2024, we consummated the initial public offering (the “IPO”) of 8,625,000 units (the “Units”), at a price of $10.00 per Unit, including 1,125,000 additional Units granted to the underwriters to cover over-allotments, if any (the “over-allotment option”), generating gross proceeds of $86,250,000. Simultaneously with the closing of the IPO, we consummated the sale of 244,250 private placement units, to our Sponsor in the Private Placement, generating gross proceeds of $2,442,500.

The proceeds of $86,250,000 from the IPO and the Private Placement were placed in the Trust Account established for the benefit of the Company’s Public Shareholders with Wilmington Trust, N.A., acting as trustee.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.